Us2.ai

Our mission is to use AI tools to improve patient outcomes and expand healthcare accessibility, democratizing echocardiography—the most commonly used cardiac risk detection tool. Us2.ai, a spin-off supported by Singapore’s Agency for Science, Technology and Research (A*STAR), is built on major cardiovascular research platforms across 11 countries. Collaborating with top echocardiography core laboratories in the U.S. and Europe, we are revolutionizing ultrasound to bring AI-enhanced imaging to all of us.